Kerr’s Civello named ‘Tarheel of the Week’ by N.C. newspaper
RALEIGH, N.C. — Kerr Drug president and CEO Tony Civello has been named "Tarheel of the Week" by the Raleigh, N.C., News & Observer.
In a story published in its Sunday edition, the newspaper emphasized Civello’s efforts to expand the healthcare services that pharmacies provide, something that has been a hallmark of his leadership of Kerr Drug.
"[Civello] wanted to be like his neighborhood pharmacist growing up, the guy down the street he went to first when he broke his nose playing football," reporter Marti Maguire wrote. "By the time he finished pharmacy school, though, the independent pharmacist was giving way to chains that dealt in greeting cards and lipstick more than health care."
The article noted the innovations that have taken place at Kerr Drug under Civello’s leadership and have been adopted by larger chains, such as flu shots, medication therapy management and counseling Medicare patients. MTM, widely recognized as an effective means of improving medication adherence, has become a major trend in pharmacy, and flu shots delivered by pharmacists are quickly becoming the norm throughout the country.
FDA reorganizes cancer division
SILVER SPRING, Md. — The Food and Drug Administration is reorganizing its division for regulating cancer drugs, the agency said Monday.
The FDA said it would rename the Office of Oncology Products the Office of Hematology and Oncology Products. The office, which is responsible for reviewing regulatory applications for pharmaceutical and biotech drugs for cancer, is overseen by the Center for Drug Evaluation and Research. Office of Oncology Products director Richard Pazdur will continue as director of the OHOP.
"Under the new office structure, the agency anticipates greater clarity and more transparent interactions with companies about the requirements to bring cancer treatments to market," CDER director Janet Woodcock said. "We don’t expect these changes to slow down pending applications; in fact, we expect to see greater efficiencies that will better support our work to get cancer treatments to patients."
The previous structure had three divisions: the Division of Hematology Products, the Division of Drug Oncology Products and the Division of Biologic Oncology Products. The new structure retains the Division of Hematology Products while creating a new Division of Hematology Oncology Toxicology and renaming the cancer drug divisions as Division of Oncology Products 1 and Division of Oncology Products 2.
"As the practice of oncology and the treatments being developed for these diseases have become more complex, we’ve recognized the need and importance of taking a more disease-specific approach to these therapies," Pazdur said. "Reorganizing the office in this manner also aligns [the] FDA with the organizational structure of leading cancer treatment centers, academic programs and the National Cancer Institute."
Train2Cheer comes to DVD
RIVER EDGE, N.J. — A new strength and conditioning program designed specifically for cheerleaders and dancers has made its way to DVD.
Train2Cheer offers a workout that is designed to increase cardio and muscular endurance, resulting in stronger cheer and dance performances. Train2Cheer is set to high-energy music and is hosted by its creator, Stacey DelPreore.
Train2Cheer, which includes a 60-minute workout video and bonus CD soundtrack, retails for $19.99.